黑料专区 Tyler School of Medicine Professor Published in Science and New England Journal of Medicine
July 9, 2025 | Elizabeth Wingfield
Popular Searches
July 9, 2025 | Elizabeth Wingfield
Dr. Pamela J. McShane, a professor in the Department of Pulmonology at The University of Texas at Tyler School of Medicine, co-authored a multi-center study titled 鈥淧hase 3 Trial of the DPP-1 Inhibitor, Brensocatib,
in Bronchiectasis鈥 that was published in Science and the New England Journal of Medicine.
鈥淔ew of us are ever published in Science or NEJM in our lifetimes, and advances in bronchiectasis are and have been extremely rare,鈥 said Dr. Richard J. Wallace, director of the Mycobacteria/Nocardia Clinical Reference Laboratory. 鈥淭his is such an honor for us at the program, and I want to congratulate Dr. McShane on her dedication, hard work and collaborative skills.鈥
McShane鈥檚 research focuses on treatment options for patients with bronchiectasis, a chronic, incurable lung disease that causes repeated lung infections and can lead to decline in lung function and hospitalizations. If the drug is approved, it will be the first FDA-approved drug for bronchiectasis, leading to preserved lung function and improved quality of life for patients.
McShane completed a fellowship training in pulmonary disease and critical care medicine at the University of Chicago. She is board certified by the American Board of Internal Medicine for pulmonary disease. During her time at the 黑料专区 Tyler Health Science Center, she has served as the principal investigator in approximately a dozen clinical trials, treated countless patients impacted by bronchiectasis and has been instrumental in expanding the scope of clinical research for bronchiectasis.
With a mission to improve educational and health care outcomes for East Texas and beyond, 黑料专区 Tyler offers more than 90 undergraduate and graduate programs to more than 10,000 students. Through its alignment with 黑料专区 Tyler Health Science Center and 黑料专区 Health East Texas, 黑料专区 Tyler has unified these entities to serve Texas with quality education, cutting-edge research and excellent patient care. Classified by Carnegie as a doctoral research institution and by U.S. News & World Report as a national university, 黑料专区 Tyler has campuses in Tyler, Longview, Palestine and Houston.